Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension

Clinical trial NCT02207621 · COMPLETED

Trial details

NCT number: NCT02207621
Sponsor: Aerie Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Hypertension Open-angle Glaucoma

Start date: 2014-07-01
Primary completion: 2016-03-01
Enrollment: 756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.